Login Register Cart 0
Research Article

MiRNA-103b Downregulates ITGB3 and Mediates Apoptosis in Ex Vivo Stored Human Platelets

Author(s): Neetu Dahiya and Chintamani Atreya*

Volume 10, Issue 2, 2021

Published on: 04 June, 2021

Page: [123 - 129] Pages: 7

DOI: 10.2174/2211536610666210604121854

open access plus

Abstract

Background: Blood bank-stored human platelets are one of the life-saving transfusion products to prevent bleeding in multiple clinical settings. In ex vivo storage, platelets undergo apoptosis and it is highly desirable to prevent this process to preserve platelet quality. However, underlying mechanisms of apoptosis are not well understood in stored platelets. Integrin beta 3 (ITGB3) glycoprotein plays multiple roles in platelet physiological processes, and it was reported in other cell types that downregulation of ITGB3 induces apoptosis. Small noncoding regulatory RNAs known as microRNAs (miRNAs), some of which are abundant in platelets such as miR-103b that belong to miR-103 family of miRNAs, known to play key roles in platelet functions both in vivo and during storage; Cellular miR-103 downregulates certain genes in other cell types and promotes apoptosis. However, whether miR-103b can target and downregulate ITGB3 in stored platelets and such miRNA regulation promotes apoptosis is not known. Here, we tested this working hypothesis.

Objective: Our objective of this study is to validate the abundance of miR-103b in stored platelets and identify whether ITGB3 is a target of miR-103b for the downregulation and this interaction promotes apoptosis.

Methods: RT-qPCR validation of miR-103b was performed in 11 donor samples at 3 different storage time points. In-silico analysis was performed to identify predicted targets of the miR-103b. The miRNA and messenger RNA interactions were confirmed using different biochemical approaches such as qRT-PCR, western blotting and, suppression of luciferase reporter gene expression by ectopic expression of miR-103b in HeLa cells. Final validation of the functional role of miR-103b in ITGB3 downregulation and resulting induction of apoptosis was assessed in stored platelets by FACS analysis following ectopic expression of miR-103b.

Results: Using the Target Scan Vert algorithm, we identified several integrin subunit-encoding mRNAs as potential targets of miR-103b. While ITGB3 and ITGB6 were found to have two targeting sites for miR-103b, since ITGB3 is known to play a role in apoptosis, we chose this for further validation in this study. Ectopic expression of miR-103b decreased the luciferase reporter activity in HeLa cells and decreased ITGB3 mRNA and protein levels in platelets, concomitant with an increase in apoptosis.

Conclusion: The results demonstrate that in stored platelets, miR-103b is highly expressed and can interact with and downregulate ITGB3 and promote apoptosis in stored platelets.

Keywords: MicroRNA, microarray, platelets, miR-103b, platelet apoptosis, ITGB3.

« Previous Next »
Graphical Abstract

[1]
Perrotta PL, Perrotta CL, Snyder EL. Apoptotic activity in stored human platelets. Transfusion 2003; 43(4): 526-35.
[http://dx.doi.org/10.1046/j.1537-2995.2003.00349.x] [PMID: 12662287]
[2]
Seghatchian J, Tolksdorf F. Characteristics of the THERAFLEX UV-platelets pathogen inactivation system - an update. Transfus Apheresis Sci 2012; 46(2): 221-9.
[http://dx.doi.org/10.1016/j.transci.2012.01.008] [PMID: 22365926]
[3]
Ohto H, Ezuki S, Kanno T, Nollet KE. Extending platelet storage: Safety and quality considerations. ISBT Sci Ser 2009; 4: 266-70.
[http://dx.doi.org/10.1111/j.1751-2824.2009.01247.x]
[4]
Leytin V. Apoptosis in the anucleate platelet. Blood Rev 2012; 26(2): 51-63.
[http://dx.doi.org/10.1016/j.blre.2011.10.002] [PMID: 22055392]
[5]
Kile BT. The role of apoptosis in megakaryocytes and platelets. Br J Haematol 2014; 165(2): 217-26.
[http://dx.doi.org/10.1111/bjh.12757] [PMID: 24467740]
[6]
Bao J, Lin L. Platelet apoptosis in patients with acute coronary syndromes. J Thromb Thrombolysis 2015; 39(4): 539-46.
[http://dx.doi.org/10.1007/s11239-014-1160-8] [PMID: 25515895]
[7]
Zhao S, Zhao J, Zhang T, Guo C. Increased apoptosis in the platelets of patients with Alzheimer’s disease and amnestic mild cognitive impairment. Clin Neurol Neurosurg 2016; 143: 46-50.
[http://dx.doi.org/10.1016/j.clineuro.2016.02.015] [PMID: 26895209]
[8]
Yougbaré I, Lang S, Yang H, et al. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage. J Clin Invest 2015; 125(4): 1545-56.
[http://dx.doi.org/10.1172/JCI77820] [PMID: 25774504]
[9]
Sesé M, Fuentes P, Esteve-Codina A, et al. Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signaling and malignant features in vitro and in vivo. Oncotarget 2017; 8(70): 114856-76.
[http://dx.doi.org/10.18632/oncotarget.23145] [PMID: 29383126]
[10]
Dahiya N, Atreya CD. MiR-181a reduces platelet activation via the inhibition of endogenous RAP1B. MicroRNA 2020; 9(3): 240-6. http://dx.doi.org/10.2174/2211536608666191026120515
[PMID: 31738148]
[11]
Dahiya N, Atreya CD. RAP1 Downregulation by miR-320c reduces platelet activation in ex-vivo storage. MicroRNA 2019; 8(1): 36-42.
[http://dx.doi.org/10.2174/2211536607666180521094532] [PMID: 29779489]
[12]
Dahiya N, Sarachana T, Kulkarni S, et al. MiR-570 interacts with mitochondrial ATPase subunit g (ATP5L) encoding mRNA in stored platelets. Platelets 2017; 28(1): 74-81.
[http://dx.doi.org/10.1080/09537104.2016.1203405] [PMID: 27561077]
[13]
Dahiya N, Kulkarni S, Atreya CD. Ingenuity pathway analysis of miRNAs and mRNAs in stored platelets identifies the potential of miRNAs in regulating platelet functions relevant to storage lesions. J Hematol Blood Transfus Disord 2016; 3: 12.
[14]
Oved K, Farberov L, Gilam A, et al. MicroRNA-mediated regulation of ITGB3 and CHL1 is implicated in SSRI action. Front Mol Neurosci 2017; 10: 355.
[http://dx.doi.org/10.3389/fnmol.2017.00355] [PMID: 29163031]
[15]
White K, Dempsie Y, Caruso P, et al. Endothelial apoptosis in pulmonary hypertension is controlled by a microRNA/programmed cell death 4/caspase-3 axis. Hypertension 2014; 64(1): 185-94.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.113.03037] [PMID: 24732886]
[16]
Park H, Huang X, Lu C, Cairo MS, Zhou X. MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins. J Biol Chem 2015; 290(5): 2831-41.
[http://dx.doi.org/10.1074/jbc.M114.591420] [PMID: 25505246]
[17]
Yang D, Wang JJ, Li JS, Xu QY. MiR-103 functions as a tumor suppressor by directly targeting programmed cell death 10 in NSCLC. Oncol Res 2018; 26(4): 519-28.
[http://dx.doi.org/10.3727/096504017X15000757094686] [PMID: 28734041]
[18]
Li F, Yao J, Hao Q, Duan Z. MiRNA-103 promotes chondrocyte apoptosis by down-regulation of Sphingosine kinase-1 and ameliorates PI3K/AKT pathway in osteoarthritis. Biosci Rep 2019; 39(10): 20191255.
[http://dx.doi.org/10.1042/BSR20191255] [PMID: 31652455]
[19]
Luo M, Li R, Deng X, et al. Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes. Acta Diabetol 2015; 52(5): 943-9.
[http://dx.doi.org/10.1007/s00592-015-0733-0] [PMID: 25820527]
[20]
Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136(2): 215-33.
[http://dx.doi.org/10.1016/j.cell.2009.01.002] [PMID: 19167326]
[21]
Plé H, Landry P, Benham A, Coarfa C, Gunaratne PH, Provost P. The repertoire and features of human platelet microRNAs. PLoS One 2012; 7(12): e50746.
[http://dx.doi.org/10.1371/journal.pone.0050746] [PMID: 23226537]
[22]
Freitas RCC, Bortolin RH, Lopes MB, et al. Integrated analysis of miRNA and mRNA gene expression microarrays: Influence on platelet reactivity, clopidogrel response and drug-induced toxicity. Gene 2016; 593(1): 172-8.
[http://dx.doi.org/10.1016/j.gene.2016.08.028] [PMID: 27543010]
[23]
Bennett JS. Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest 2005; 115(12): 3363-9.
[http://dx.doi.org/10.1172/JCI26989] [PMID: 16322781]

Rights & Permissions Print Cite
Article Metrics
31
1
© 2024 Bentham Science Publishers | Privacy Policy